总化的强力克隆性发作中的焦点电临床特征:诊断挑战的决策流程图
Maria Vlachou1,2, Philippe Ryvlin3, Sidsel Armand Larsen4
1Department of Clinical Neurophysiology, Aarhus University Hospital, Aarhus, Denmark.
Epilepsia
|January 27, 2024
概括
焦点特征,如头部版本和EEG异常在异常性泛性 (IGE) 中很常见,但很少表明焦点发作. 在这些情况下,新的流程图准确地区分了焦点和泛性.
科学领域:
- 神经学 神经学
- 发病学 (Epileptology) 是一个专业的学科.
- 临床神经生理学 临床神经生理学
背景情况:
- 具有焦点特征的双边性-克隆性发作可能被误诊为焦点,导致治疗不正确.
- 区分焦点和泛性对于有效的治疗至关重要.
研究的目的:
- 为了确定焦点特征的患病率和预后价值在异形性通用性 (IGE).
- 制定决策流程图,以区分双边强力克隆发作和焦点发现的患者的焦点和泛性.
主要方法:
- 从60名患者的视频电脑电图 (EEG) 记录进行了回顾性分析 (18名IGE,42名焦点).
- 在至少1年的随访后,评估形学,间和间EEG模式,以及治疗反应.
- 开发和评估一个决策流程图,基于互触电脑电路协同.
主要成果:
- 在75%的发作和77.8%的IGE患者中发生了焦点语义 (例如,头部版本).
- 在61.1%的IGE患者中存在着焦点间接性形放电 (IED);焦点间接性EEG发作很少 (16.7%).
- 一个决策流程图在区分焦点和泛性方面取得了96.6%的准确性.
结论:
- 在IGE中,焦点半径学和直径EEG发现是常见的,但焦点直径发作不常见.
- 这些焦点特征似乎不会影响IGE的治疗反应.
- 评估间脉冲-间脉冲EEG一致性是精确症分类的关键.
更多相关视频
10:23Equipment Setup and Artifact Removal for Simultaneous Electroencephalogram and Functional Magnetic Resonance Imaging for Clinical Review in Epilepsy
Published on: June 23, 2023
2.0K
06:45Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue
Published on: January 19, 2019
9.0K
相关概念视频
Seizures: Classification
362
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
362
Arteries of the Lower Limbs
190
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
190
Antiepileptic Drugs: GABAergic Pathway Potentiators
403
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
403
Electroconvulsive Therapy
41
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
41
